Skip to main content
Fig. 3 | Biomarker Research

Fig. 3

From: Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia

Fig. 3

Progenitor (T-bethiEomesdim/−PD1mid) and terminally (T-betdim/−EomeshiPD1hi) exhausted CD8+ T cells in progressing and non-progressing CLL patients. a Percentages of T-bethiEomesdim/− out of PD1midCD8+ T cells and b T-betdim/−Eomeshi out of PD1hiCD8+ T cells in progressing (left, n = 12) and non-progressing patients (middle, n = 9) at diagnosis and progression or non-progression. Fold change between time points of both subsets comparing progressing and non-progressing patients (right). c Representative viSNE plots of PD1, T-bet and Eomes expression in CD4+ and CD8+ T cells at the two time points from one representative patient from each group. Graphs show mean ± SEM or paired values. (*P < 0.05; **P < 0.01; ***P < 0.001; Wilcoxon matched paired test or Mann-Whitney test)

Back to article page